The largest database of trusted experimental protocols

Multiplex elisa assay

Manufactured by Mesoscale
Sourced in United States

The Multiplex ELISA assay is a laboratory equipment used to detect and quantify multiple target analytes in a single sample. It employs the enzyme-linked immunosorbent assay (ELISA) principle to simultaneously measure the presence and concentration of different proteins or other biomolecules in a sample.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using multiplex elisa assay

1

Multiplex ELISA Assay for Cytokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell-free cell culture supernatant samples were stored at −20°C until analyzed. The system used was a multiplex ELISA assay manufactured by Meso Scale Discovery (MSD, Gaithersburg, MD, USA) containing 10 individual ELISAs per well. Supernatants were tested with a U-PLEX Proinflammatory Panel1 Human Kit [a multiplex 96-well ELISA plate based assay that contained primary antibodies to IL-12, IL-10, TNFα, IL-6, IL22, interleukin 1 receptor antagonist (IL-1Ra), interferon alpha 2a (IFNα2a), interferon beta (IFNβ), interferon gamma (IFNγ), and IL-1β] per manufacturer’s recommendations. Briefly, the MSD plex assays were run as follows. Calibration curves were prepared in the supplied assay diluent for human serum, with a range of 40,000–1.2 pg/ml, depending on the cytokine. Arrays were preincubated with 25 µl per well of assay diluent for 30 min. After the pre-incubation, 25 μl sample or calibrator was added in duplicate to the appropriate wells. The array was then incubated at room temperature for 2 h with primary antibody. The array was washed with PBS plus 0.05% Tween 20, and 25 µl detection antibody reagent was added. After 2 h of incubation at room temperature with secondary antibody, the array was washed, and the detection buffer was added. Results were read with a QuickPlex SQ 120. Sample cytokine concentrations were determined using MSD Discovery Workbench 4.0 software.
+ Open protocol
+ Expand
2

Cytokine Profile in Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Baseline clinicodemographic data at ADT initiation was obtained such as age, ECOG PS, PSA, extent of metastases (high versus low based on CHAARTED criteria), and de novo versus metachronous disease presentation (based on whether or not patients had prior local therapy, e.g., radical prostatectomy, radiation). Outcomes data was captured including follow-up time, time to CRPC, and OS. The Fichorova Laboratory at Brigham and Women’s Hospital assessed all serum cytokine levels using the same Mesoscale Discovery Multiplex ELISA assay employed in the discovery cohort and is detailed previously.15 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!